article thumbnail

Extremely Severe Pediatric Obesity Prevalence Increased Over Last 15 Years

Drug Topics

1 From 2008 to 2023, the relative increase of pediatric patients with obesity classes 4 to 5 is 253.1%. 3 In the current review, investigators used data from 25,847 patients from the National Health and Nutrition Examination survey from 2008 to 2023. Approximately 53.9% Approximately 20.3% were Mexican American, 23.9% Approximately 20.3%

article thumbnail

Gedeon Richter launches Nalvee in UK to expand HRT options for menopause

Pharma Times

Nalvee is a branded generic of a product first introduced in 1961 but withdrawn from the UK market in 2008 due to declining HRT use. The oral tablet offers clinicians a new progestogen option for non-hysterectomised women receiving oestrogen therapy. Dydrogesterone closely mimics natural progesterone and is highly bioavailable.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Five Things For Pharmacists To Know About The Treatment Of Mycobacterium Tuberculosis

IDStewardship

Acta Ophthalmol. 2015;93:402–10. doi: 10.1111/aos.12515. Chan RY, Kwok AK. Ocular toxicity of ethambutol. Hong Kong Med J. 2006;12:56–60. Choung, H. H., & Yu, Y. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. Journal of Neuroophthalmology, 28(4), 269-277 16. Peloquin CA, Ebert SC. Tuberculosis. editors.

article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

This commitment, combined with her vision and leadership, led to the launch of PolicyMap in 2008. Drawing on her career in city, state, and federal government, McCullough has dedicated her work to making complex information accessible and actionable.

article thumbnail

HHS Adopts ACIP Recommendation to Eliminate Thimerosal From Flu Shots

Drug Topics

Extremely Severe Pediatric Obesity Prevalence Increased Over Last 15 Years Ashley Gallagher July 22nd 2025 Article From 2008 to 2023, the relative increase of pediatric patients with obesity classes 4 to 5 was 253.1%.

article thumbnail

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

Pharmacy Times

Eligible patients include adults (≥ 18 years) diagnosed with CML receiving imatinib as first-line therapy for more than 1 month between 2008 and 2023. Materials and Methods This retrospective observational study utilized the Carolina Data Warehouse for Health electronic health record (EHR) database.

article thumbnail

GLP-1s Lower Mortality, Neurodegeneration Risks

Drug Topics

Recent Videos Related Content Extremely Severe Pediatric Obesity Prevalence Increased Over Last 15 Years Ashley Gallagher July 22nd 2025 Article From 2008 to 2023, the relative increase of pediatric patients with obesity classes 4 to 5 was 253.1%. Subscribe Now!